Mattis Ranthe, MD, PhD
Mattis Ranthe, MD, PhD
Unknown affiliation
Verified email at ssi.dk
TitleCited byYear
Familial aggregation of lone atrial fibrillation in young persons
N Øyen, MF Ranthe, L Carstensen, HA Boyd, MS Olesen, SP Olesen, ...
Journal of the American College of Cardiology 60 (10), 917-921, 2012
1002012
Risk of ischaemic heart disease in patients with inflammatory bowel disease: a nationwide Danish cohort study
C Rungoe, S Basit, MF Ranthe, J Wohlfahrt, E Langholz, T Jess
Gut 62 (5), 689-694, 2013
882013
Association between hypertensive disorders of pregnancy and later risk of cardiomyopathy
I Behrens, S Basit, JA Lykke, MF Ranthe, J Wohlfahrt, H Bundgaard, ...
Jama 315 (10), 1026-1033, 2016
692016
Risk of cardiovascular disease in family members of young sudden cardiac death victims
MF Ranthe, BG Winkel, EW Andersen, B Risgaard, J Wohlfahrt, ...
European heart journal 34 (7), 503-511, 2012
602012
Pregnancy loss and later risk of atherosclerotic disease
MF Ranthe, EAW Andersen, J Wohlfahrt, H Bundgaard, M Melbye, ...
Circulation 127 (17), 1775-1782, 2013
532013
Family history of premature death and risk of early onset cardiovascular disease
MF Ranthe, L Carstensen, N Øyen, J Tfelt-Hansen, M Christiansen, ...
Journal of the American College of Cardiology 60 (9), 814-821, 2012
482012
Cardiac involvement in myotonic dystrophy: a nationwide cohort study
M Lund, LJ Diaz, MF Ranthe, H Petri, M Duno, I Juncker, H Eiberg, ...
European heart journal 35 (32), 2158-2164, 2014
462014
Atypical antipsychotics olanzapine, quetiapine, and risperidone and risk of acute major cardiovascular events in young and middle-aged adults: a nationwide register-based …
B Pasternak, H Svanström, MF Ranthe, M Melbye, A Hviid
CNS drugs 28 (10), 963-973, 2014
182014
A detailed family history of myocardial infarction and risk of myocardial infarction–a nationwide cohort study
MF Ranthe, JA Petersen, H Bundgaard, J Wohlfahrt, M Melbye, HA Boyd
PloS one 10 (5), e0125896, 2015
172015
Rare truncating variants in the sarcomeric protein titin associate with familial and early-onset atrial fibrillation
G Ahlberg, L Refsgaard, PR Lundegaard, L Andreasen, MF Ranthe, ...
Nature communications 9 (1), 4316, 2018
122018
Risk of cardiomyopathy in younger persons with a family history of death from cardiomyopathy: a nationwide family study in a cohort of 3.9 million persons
MF Ranthe, L Carstensen, N Øyen, MK Jensen, A Axelsson, J Wohlfahrt, ...
Circulation 132 (11), 1013-1019, 2015
92015
Hypertensive disorders of pregnancy and peripartum cardiomyopathy: A nationwide cohort study
I Behrens, S Basit, JA Lykke, MF Ranthe, J Wohlfahrt, H Bundgaard, ...
PloS one 14 (2), e0211857, 2019
72019
Association between pregnancy losses in women and risk of atherosclerotic disease in their relatives: a nationwide cohort study
MF Ranthe, LJ Diaz, I Behrens, H Bundgaard, J Simonsen, M Melbye, ...
European heart journal 37 (11), 900-907, 2015
62015
& Fullerton, HJ (2014)
AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha
Heart disease and stroke statistics-2014 update. Circulation 129 (3), 143-152, 0
6
Lower rates of cardiovascular events and mortality associated with liraglutide use in patients treated with basal insulin: A DEVOTE subanalysis (DEVOTE 10)
K Brown‐Frandsen, SS Emerson, DK McGuire, TR Pieber, NR Poulter, ...
Diabetes, Obesity and Metabolism 21 (6), 1437-1444, 2019
42019
Insulin degludec/liraglutide (IDegLira) was effective across a range of dysglycaemia and body mass index categories in the DUAL V randomized trial
I Lingvay, S Harris, E Jaeckel, K Chandarana, MF Ranthe, E Jódar
Diabetes, Obesity and Metabolism 20 (1), 200-205, 2018
42018
Miscarriage and cardiovascular disease
MF Ranthe, HA Boyd
Heart 101 (24), 1933-1934, 2015
42015
Superior HbA1c control with the fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) compared with a maximum dose of 50 units of insulin degludec in Japanese …
H Watada, S Kaneko, M Komatsu, BR Agner, T Nishida, M Ranthe, ...
Diabetes, Obesity and Metabolism, 2019
12019
Insulin degludec/liraglutide (IDegLira) maintains glycaemic control and improves clinical outcomes, regardless of pre‐trial insulin dose, in people with type 2 diabetes that is …
L Meneghini, A Doshi, D Gouet, T Vilsbøll, K Begtrup, P Őrsy, MF Ranthe, ...
Diabetic Medicine, 2019
12019
Co-occurrence of infantile hypertrophic pyloric stenosis and congenital heart defects: a nationwide cohort study
B Feenstra, S Gørtz, M Lund, MF Ranthe, F Geller, M Melbye
Pediatric research 85 (7), 955, 2019
12019
The system can't perform the operation now. Try again later.
Articles 1–20